Do you or a loved one take medication for high blood pressure or a heart condition that contains valsartan? Or have you taken valsartan-containing medicine in the past? You could be at risk for certain cancers due to “unexpected impurities” discovered in some of these drugs.
Now the subject of an expanding recall and FDA investigation, valsartan is a generic ingredient contained in medications produced by a long list of drug manufacturers. And, while not all valsartan is being recalled, that originating from Zhejiang Huahai Pharmaceuticals (Huahai) in China, has been found to be contaminated by probable carcinogens.
This means that long-term use of medications made with the tainted valsartan may cause cancer, particularly of the liver or colorectal systems, according to medical professionals and researchers.
To date, some valsartan has been found by the US Food and Drug Administration, as well as other international regulatory entities like the European Medicines Agency, to be contaminated with two different cancer-causing chemicals: N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA).
The contamination issue was first brought to light in July 2018, when Indian drug manufacturer Torrent Pharmaceuticals Limited, informed the FDA that they had found NDMA in the valsartan they had been using as the active pharmaceutical ingredient (API) in several products. Most of this contaminated valsartan had been produced by Huahai.
Torrent began a voluntary product recall at that time, and the FDA initiated their own testing, as well as inspections of Huahai’s facilities in eastern China to determine what had caused the contamination. More recently, as a result of the investigations and laboratory testing of both tainted and safe valsartan, the additional NDEA contamination was discovered in some products also originating from Huahai.
The FDA has put the Chinese manufacturer on an import alert as of late September 2018, which means they are now banned from importing their products into the United States. However, the contamination problem may have begun as early as 2012, according to reporting from Reuters.
If you have a current prescription for valsartan or a valsartan-containing medication, there are several courses of action you can take right away:
Because the tainted valsartan may have been on the market since 2012 or 2013, according to investigative reports, long-term exposure to the cancer-causing NDMA and NDEA chemicals is possible. If you have taken valsartan in the past and then developed cancer, especially of the liver, or if you’ve sustained other serious liver problems, you may be a victim of defective valsartan.
The good news is that you may have legal options to recover compensation for your injuries, and we would love to consult with you here at Westmoreland Injury Lawyers.
Don’t wait. If you or a loved one has developed cancer or suffered other injuries that you suspect may be related to taking valsartan, you may have a case. Contact us now to discuss your options for FREE. Our experienced attorneys have been fighting back against unethical practices in the pharmaceutical industry for over 25 years, and we are here to help YOU.